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The phenomenon  of immune tolerance after  ingestion  of antigen  was reported  as 
early  as  1911  when  Wells  demonstrated  that  guinea  pigs  fed  ovalbumin  lost  the 
ability to develop systemic anaphylaxis  (1). These observations were expanded in the 
classic experiments of Chase in  1946 (2), demonstrating inhibition  of delayed hyper- 
sensitivity to dinitrochlorobenzene  by prior feeding.  Loss of systemic reactivity after 
oral  feeding has  now been demonstrated  in several  different  models  (3-10).  Mice or 
rats fed sheep erythrocytes show a  diminished  ability to form plaque-forming cells in 
the spleen after intraperitoneal challenge, which was ascribed to serum factors in some 
studies (5, 6) and to suppressor cells in others (7).  In addition to suppression of delayed 
hypersensitivity (8), antigen-induced DNA synthesis of murine lymph node cells after 
subcutaneous challenge (9) can also be suppressed by prior intragastric administration 
of soluble protein antigens. 
Thus,  in various animal  models and with different  antigens  and assays, a  general 
phenomenon  has  been  observed,  that  deposition  of antigen  in  the  gut  may,  under 
certain  circumstances,  lead  to  inhibition  of an  immune  response  to  a  subsequent 
parenteral  injection of the specific antigen. There is, however, disagreement  as to the 
mechanisms  involved  and  it  is  possible  that  different  mechanisms  are  operative  in 
different  systems.  It  also  appears  that  gut-associated  lymphoid  tissue  (GALT), 1 
particularly  Peyer's patches  (PP)  and  mesenteric  lymph nodes  (MLN),  may play a 
central role in the induction of systemic suppression by the oral route (7,  10). 
PP  cells  also  appear  to have a  major role  in  the  distribution  of antigen-sensitive 
cells  to the  secretory immune  system  (11-13).  Deposition  of antigen  in  the  gut  has 
been shown to lead to the production of IgA antibodies  in secretions  at  sites  distant 
from  the  gut  such  as  colostral,  lacrimal,  and  salivary  secretions  in  man  (14),  and 
salivary secretions in the rhesus monkey (15)  and rats  (16). It appears,  therefore, that 
the secretory immune system can be stimulated centrally, and that precursors of IgA- 
producing cells  migrate  from the GALT to several  secretory sites  in addition  to the 
lamina propria of the gut. 
In view of these observations, it seemed possible that intragastric administration  of 
soluble or particulate  antigen  might  lead  to concurrent  induction  of secretory anti- 
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bodies and systemic suppression. The objectives of this investigation were to examine 
this possibility using Streptococcus  mutans bacterial cells as an example of a  particulate 
antigen, and to compare the results with those obtained using the soluble antigens 
ovalbumin and  keyhole  limpet  hemocyanin.  The  results  indicate  that  secretory 
immunity and systemic tolerance may appear concomitantly after oral immunization 
with  these  antigens, and  are  associated  with  the  development of antigen-specific 
suppressor cells. 
Materials and Methods 
Animals.  8- to  12-wk-old CBA/J mice were obtained from The Jackson Laboratory, Bar 
Harbor, Maine. 
Antigens.  S. mutans Ingbritt (serotype c) was kindly supplied by Dr. C. Schachtele, University 
of Minneapolis (Minneapolis, Minn.), and was grown for 48 h in Todd-Hewitt broth at 37°C, 
harvested by centrifugation at 6,000 g, and formalinized in phosphate-buffered formalin for 24 
h.  Cell walls were  prepared  by ultrasonication on a  Branson W200P ultrasonicator (Heat 
Systems-Ultrasonics, Inc., Plainview, N. Y.) The cells from 1 liter of broth were placed in 10 ml 
of saline and sonicated for 20 min. Whole cells were removed by centrifugation at 4,000  rpm 
for 15 min, or longer if any Gram-positive material remained in the supernate. Cell walls were 
recovered by centrifugation at  10,000 rpm for 30 min and washed three times in saline. The 
preparation was lyophilized and resuspended in saline at 5 mg/ml. 
Ovalbumin (OVA)  was  obtained from  Sigma Chemical Company, St.  Louis,  Mo.,  and 
keyhole limpet hemocyanin (KLH) was obtained from Pacific Biomarine Supply Co., Venice, 
Calif. 
Preparation  of Cell  Suspensions.  Cell  suspensions from  lymph  nodes,  spleen,  or  PP  were 
prepared as described (17). For cell transfer experiments, cells were suspended at 2 ×  10S/ml in 
RPMI-1640 medium (Grand Island Biological  Co.,  Grand Island, N. Y.), and supplemented 
with 100/~g/ml streptomycin and 100 U/ml penicillin. Residen  "~eritoneal exudate cells were 
obtained by flushing the peritoneal cavity with 5-6 ml of cold It  aks' balanced salt solution. 
Proliferative Assay.  Animals were injected subcutaneously at the " ase of the tail with 100/~1 
of antigen emulsified in H37 Ra adjuvant (Difco Laboratories, Detroit, Mich.) as previously 
described (18). 8 d later a suspension of cells from the inguinal  and paraaortic lymph nodes was 
prepared in RPMI 1640 that contained 100 #g/ml streptomycin, 100 U/ml penicillin, 25 mM 
HEPES buffer, 2 mM glutamine (Gibco Laboratories), and supplemented with 2.5% vol:vol 
pooled AB positive heat-inactivated human serum. 4 ×  105 cells in 200 ~1 media were incubated 
for 4 d with various concentrations of S.  mutans  cells or cell walls, purified protein derivative 
(PPD)  (Connaught Laboratories, Toronto, Canada)  50  /~g/ml,  OVA  500  /tg/ml, mitogens 
lipopolysaccharide (LPS)  (Difco  Laboratories) 40 ~g/ml, and concanavalin A  (Con A)  (ICN 
Nutritional Biochemicals, Cleveland, Ohio)  4 /~g/ml final concentration.  1 /~Ci of tritiated 
thymidine (New  England Nuclear, Boston, Mass.)  was added per well for  the final  18 h  of 
incubation. In comparative experiments, results were  expressed  as  stimulation indices. All 
cultures were performed in triplicate and the mean counts per minute --. SE recorded. 
Samples.  Serum was collected from clotted blood obtained from the tail. Saliva was obtained 
by injecting 1 mg of pilocarpine intraperitoneally and allowing the animals to salivate into 
small glass test tubes. Saliva was centrifuged at 4,000 rpm to remove debris. Samples were heat- 
inactivated at 56°C for 30 min and absorbed with 0.25 vol packed sheep erythrocytes (SRBC) 
for  1 h  at  room temperature.  Saliva samples were made isotonic before absorption by the 
addition of 2 mg/ml 0.14 M NaCl. 
Passive Hemagglutination  Test.  Cell walls of S.  mutans  (2.5 mg/ml) or OVA (2/~g/ml) were 
coated onto SRBC by the chromic chloride method. Briefly, 0.5 ml of antigen was mixed with 
0.5 ml of a 50% solution of SRBC in saline, and 0.5 ml of a fresh solution of chromic chloride 
(1  mg/ml) added dropwise with continuous stirring. After  l0 min at room temperature, the 
sensitized cells were resuspended at  1% in phosphate-buffered saline (PBS), pH 7.2. 
Duplicate doubling dilutions (25/~l) of murine saliva or serum samples were made, and 25 
p.l of sensitized cells added to one series, and unsensitized cells to the other as a control. Cells 
were allowed to settle for  18 h at 4°C before reading. S. J.  CHALLACOMBE AND T.  B.  TOMASI, JR.  1461 
To examine the class specificity of salivary antibodies, samples were absorbed with an equal 
volume of a  1:5 dilution of anti-murine IgG, IgA, or IgM previously incubated with whole cells 
of S.  mutans  or erythrocytes coated with OVA. After incubation  for  1 h  at  37°C and  18 h  at 
4°C,  the  samples  were  centrifuged  at  15,000  rpm  for  30  min,  and  the  antibody  activity 
compared with samples that  had been treated with saline. 
lntragastric  Immunization.  Animals  were  anesthetized  with  ether  and  a  21-gauge  needle 
inserted  into the stomach.  A  hollow steel ball of 2 mm diameter had  been soldered onto the 
blunted end. In most experiments mice were given 109 whole cells of S.  mutans,  or to 20 mg of 
OVA or KLH in 0.5 ml of PBS. Control animals were given 0.5 ml of PBS alone. 
Nylon  Wool Treatment.  Enrichment of T  cell population was performed by passage of whole 
cells through nylon wool according to a modification of the method of  Julius et al. (19). Briefly, 
1.2 g of type 200 nylon wool (Fenwal Laboratories, Inc., Morton Grove, Ill.) was loosely packed 
into a  10-ml syringe and autoclaved. Columns were presoaked with warm  (37°C)  RPMI-1640 
that contained 5% fetal calf serum (FCS) for 1 h, and then 10  s cells applied and allowed to flow 
slowly into the matrix at 37°C. Every 15 min the cells were washed further into the matrix with 
2.5 ml warm medium. This was repeated a total of four times. At the end of the incubation, the 
nonadherent cells were eluted with  18-20 ml of medium. The adherent cells were obtained by 
washing of the nylon wool in a  petri dish with cold medium.  Recovery of viable nonadherent 
cells was ~30% for spleen, 40% for MLN cells, and 25% for PP. When nylon wool nonadherent 
cells were assayed by the fluorescent antibody test for light chain-bearing cells, those from MLN 
contained <4% anti-kappa-staining cells, and those from PP and spleens ~6%. 
Transfer  Experiments.  Single  cell  suspensions  of spleen,  PP,  or  MLN  were  prepared  as 
described from animals immunized intragastrically with S. mutans, OVA, or PBS. 40 ×  10  s cells 
were given intravenously  into syngeneic  recipients;  1 h  later  these animals  were challenged 
subcutaneously in the base of the tail with  100 #g of OVA, or 5 ×  10  r S. mutans cells in H37 Ra 
adjuvant. 
Results 
Proliferative Assay with S. Mutans.  An in vitro dose-response curve was obtained with 
whole cells or cell wall  preparations  from  S.  mutans  in  H37  Ra  adjuvant  in  CBA/J 
mice immunized  8  d  previously. The  optimal  immunizing  dose was  found  to be 5  × 
107 cells, and the optimal in vitro concentrations were 2  ×  l0  s  for whole cells and  2.5 
mg/ml  for cell walls  (Fig.  1).  Cell walls consistently  elicited a  greater response  than 
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FIG.  1.  Proliferative assay with S. mutans cells and walls. In vitro dose-response curve. Mean counts 
per minute of triplicate cultures in 4-d assays of LNC from immunized or control (nonimmunized) 
mice.  Animals immunized 8 d  previously with 5 ×  10  s S.  mutans in  H37  Ra complete adjuvant. 
Walls --  S.  mutans cell walls  prepared  by uhrasonication.  Cells  =  intact  formalinized cells of S. 
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whole cells. The preparations did not  appear to have significant mitogenic activity 
because the counts obtained with control cells from unimmunized animals were not 
significantly greater than background. 
Inguinal  and  paraaortic  lymph  node  cells  (LNG)  were  removed  from  animals 
immunized subcutaneously with S. mutans, and T  and B cell preparations obtained on 
nylon columns as described in Materials and Methods. The T-enriched preparation 
(hereafter called T  cells) contained 4%  anti-kappa-staining cells and 95%  anti-Thy- 
1.2 positive cells, whereas the B-enriched preparation (B cells) contained 2% anti-Thy- 
1.2  positive cells and  ~65%  positive anti-kappa cells. T  cells showed  a  significant 
response to both whole cells and cell walls (Table I). The responses were increased to 
the  levels  found  in  unfractionated  cells by  the  addition of 5%  resident  peritoneal 
exudate  cells  (PEC)  that  had  been  irradiated  (3,300  rad).  Treatment  of sensitized 
LNC with anti-Thy-1.2 +  complement eliminated proliferation. B cells did not show 
a  response to whole S.  mutans when  supplemented with  PEC,  and responded to cell 
wall preparations only if 10% or greater PEC were added, and then the response was 
<20% of that given by whole LNC. Thus,  it appears that the assay is T  dependent, 
and the proliferating cell is primarily a  T  cell. 
Effect of Intragastric  (IG) Immunization with 0 VA.  A  single intragastric dose of OVA 
was given to 8-wk-old CBA/J  mice, followed 7 d  later by subcutaneous challenge. As 
little as 1 mg of OVA given intragastrically led to >80% suppression of the proliferative 
response  in  draining lymph  nodes,  compared  with  animals  given  PBS  IG  (Fig.  2). 
Saliva  taken  from  mice  14  d  after  OVA  IG  (which  had  not  been  challenged 
subcutaneously) showed antibody titers of up to 1:32. The mean titer in animals given 
10 mg of OVA IG was 3.5 +  0.5, whereas antibodies were not consistently detected in 
animals given  1 mg or less of OVA  IG. Results similar to those shown in Fig. 2 were 
obtained in two additional experiments, each employing five experimental and  five 
control  mice.  No  serum  antibodies  were  detected  in  any  group  after  intragastric 
immunization alone, nor when  intragastric immunization was  followed by subcuta- 
neous  immunization.  These  observations  indicated that  intragastric immunization, 
TABLE  I 
Proliferative Response in LNC to S. mutans 
LNC  Medium  Cell wall  Whole cells 
Whole LNC  2,245 ±  1,019  14,901 ±  1,225  5,609 ± 271 
T cells  377 ± 38  6,159 + 617  2,866 ± 47 
+  1% PEC  400 ± 95  7,558 + 393  3,877 ±  707 
+  2% PEC  215 ± 24  13,172 ±  791  3,803 +  760 
+  5% PEC  272 ± 62  13,023 ± 2,160  6,840 ±  76 
+  10% PEC  340 ± 28  13,450 + 560  6,738 + 601 
B cells  623 ± 63  523 ±  11  485 ± 62 
+  5% PEG  561 ± 224  412 ±  194  ND 
+  10% PEC  1,215 ±  112  2,426 ± 32  886 ±  121 
+ 20% PEC  1,132 ± 59  2,590 ± 509  628 ± 93 
PEC 20%  118 ±  12  286 + 57  202 ±  10 
T cells -- 4% anti-kappa were >95% anti-Thy-l.2 positive. B cells = >65% anti-kappa were 2% anti-Thy- 
1.2 positive. %  SUPPRESSION: 
LNC  25 -- 
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Fro. 2.  Salivary antibodies and systemic  suppression after intragastric administration of OVA in 
CBA/J mice. Results show mean :1: SE of four to six mice/group. Animals were given OVA or PBS 
IG, and 7 d later challenged subcutaneously with 100 #g OVA in H37 Ra complete adjuvant. 8 d 
later  (day 15), samples of serum and saliva were taken and the proliferative assay performed. 
Salivary antibody titers were assayed by hemagglutination as described in Materials and Methods. 
No serum antibodies were detected. 
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Fie.  3.  Salivary antibodies and systemic  suppression after intragastric administration of S. mutans 
in CBA/J mice. Results expressed as mean :t: SE of three animals/group. Mice given  S. mutans or 
PBS IG and 7 d  later challenged subcutaneously with 5  X  10  s  S.  mutans  in H37  Ra complete 
adjuvant.  8 d  later  (day 15)  samples of serum and saliva obtained and the proliferative assay 
performed. Antibody titers assayed by hemagglutination. No serum antibodies detectable. 
with defined concentrations of antigen, gives rise to salivary antibodies and systemic 
suppression concurrently. 
Effect of Intragastric  Immunization  with S.  Mutans.  Mice given l0  s S.  mutans IG did not 
show significant suppression of the proliferative response to S. mutans when challenged 
7 d  later. However, a  dose of 109 or greater induced suppression as revealed by the 
proliferative assay against cell wall antigen or whole cells (Fig. 3). The suppression 
was  not  as  great  as  that  found with OVA.  Suppression was  somewhat  greater  for 
whole cells  (maximum 70%)  than for cell walls (maximum 58%).  This was just the 
reverse of their potency in stimulating proliferation in the regional lymph node when 
given subcutaneously in the  tail  (compare Fig.  3  with Fig.  1).  Significant salivary 
antibody titers were detectable in animals given 2.5 or 5 ×  10  a S.  mutans IG with mean 
titers of 3.2 +  0.4 and 2.5 +  0.5, respectively. No serum antibodies were detected after 1464  SECRETORY  ANTIBODIES  AND SYSTEMIC  TOLERANCE 
intragastric immunization nor after subcutaneous challenge in the LNC proliferative 
assay. Two additional experiments showed very similar results. 
Kinetics  of Suppression  of Proliferative  Response  after  Intragastric  Immunization.  Mice 
challenged subcutaneously with OVA  2 d  after intragastric administration of 20 mg 
OVA showed suppression of the LNC proliferative response by -85%, compared with 
mice given PBS (Fig. 4). Maximum suppression was found when mice were challenged 
subcutaneously 4-7 d after IG administration, but suppression of 60% was still evident 
when animals were challenged 60 d  later. 
With  S.  mutans,  the  suppression  was  not  as  profound  as  with  OVA,  and  the 
maximum  suppression  was  ~70%  at  7  d  after  intragastric administration  (Fig.  5). 
After day  14, suppression rapidly diminished and by day 30 was no longer evident. 
Specificity of Suppression.  Induction of suppression appeared to be specific because 
mice that had received 20 mg OVA  or  15  mg KLH  were challenged  7 d  later; only 
those animals challenged with the homologous antigen showed significant suppression 
(Fig. 6). Mice primed with OVA showed suppression when challenged with OVA but 
not with KLH, and vice versa. Although the induction of suppression was specific, a 
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FIG. 4.  Kinetics of suppression of the proliferative response after intragastric  administration of 
OVA. CBA/J mice challenged subcutaneously with 100/.tg OVA in H37 Ra complete adjuvant 2- 
60 d after single intragastric administration of 20 mg OVA. Results indicate mean + SE of in vitro 
proliferative response (measured as SI) in three to five mice/group. 
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FIG. 5.  Kinetics of suppression of the proliferative response after intragastric administration of S. 
mutans. CBA/J mice challenged subcutaneously with 5 ×  10  a S. mutans in H37 Ra complete adjuvant 
2-30 d after single intragastric  administration of 109 S. mutans. Results indicate mean +  SE of in 
vitro proliferative response (measured as SI) in four to five mice/group. S. J.  GHALLACOMBE  AND  T.  B.  TOMASI, Js. 
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1465 
--30/I  ../ 
stimulation 
index (± SE) 
20-- 
,o-/  i 
o  m~  ~  ..,. ,m  --.- 
,o  pBs  KLH  OVA  PeS  KLH OVA  f'BS OVA KL.  PBS  OVA  KL. 
SC  KLH  KLH  KLH  KLH  KLH KLH  OVA OVA OVA  OVA OVA OVA 
FIc.  6.  Specificity of suppression of proliferative response  by prior intragastrie administration of 
antigen. Mice received either PBS, 15 mg KLH, or 20 mg OVA by intragastric intubation. Animals 
were  immunized subcutaneously 7  d  later with  100  ~tg of OVA  or  KLH  in  H37  Ra  complete 
adjuvant. Proliferative responses were assayed 8 d  later. Mean _  SE of three to four mice/group. 
In vitro response to: 
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FIo.  7-  S~ecificity  of suppression  induced  by  intragastric  immunization with  S.  rautans.  Mice 
received  l0  S. mutans or Lactobaciltus easel, or 20 mg OVA IG, and were challenged subcutaneously 
7 d  later with 5 X  108 S. mutans or 100/~g OVA in H37 Ra complete adjuvant. Mean :t: SE of SI in 
groups of four to five mice. 
m 
nonspecific  component  was  also  noted.  When  suppression  was  induced  with  the 
specific antigen,  not  only was the proliferative response to that  antigen  suppressed, 
but also the response to PPD and LPS (P <  0.05). Some suppression of the mean Con 
A response was noted, but this was not statistically significant. 
Suppression  induced  by  S.  mutans  was  also  found  to  be  specific.  Intragastric 
administration  of S.  mutans  did not  affect the response to a  subcutaneous  challenge 
with OVA, but suppressed the response to S.  mutans  (Fig.  7). Conversely, intragastrie 
administration of OVA led to suppression of the response to OVA but not to S. mutans. 
IG administration of 109 Lactobacillus casei (ATCC 393) did not affect the proliferative 
response to S.  mutans. 
Class of Salivary Antibodies.  Absorption of saliva samples with anti-IgA consistently 
reduced the hemagglutinating antibody titer to either OVA or S.  mutans by two log2 1466  SECRETORY  ANTIBODIES  AND  SYSTEMIC  TOLERANCE 
steps  or  greater.  Absorption  with  anti-IgG  had  no  effect,  whereas  with  anti-IgM  a 
slight (one log2)  but  consistent reduction  in the antibody  titer was found  (Table II). 
Transfer of Suppression.  Transfer  of 40 ×  106 PP cells from mice given 20 mg OVA 
IG to syngeneic recipients resulted  in slight suppression of the proliferative response 
to  OVA,  but  this  did  not  prove  to  be  statistically  significant  (Fig.  8).  However, 
transfer of MLN  cells resulted in ~70%  suppression of the OVA  response in compar- 
ison with animals who had been given cells from PBS control animals  (P <  0.03). The 
degree of suppression was similar with cells taken  2  or 4  d  after intragastric adminis- 
tration of OVA.  Suppression was antigen-specific because the response to KLH,  PPD, 
TABLE  II 
Class Specificity  of Salivary  Antibodies  Induced by 1G lrnmunization  with OVA or S.  mutans 
Log2 hemagglutination titer after absorption with: 
Saline  Anti-IgG  Anti-IgA  Anti-IgM 
OVA 
S. mutans 
2  2  0  1 
3  3  0  2 
3  3  1  1 
2  2  0  2 
2.5 +  0.3*  2.5 +  0.3  0.2 +  0.3  1.5 4- 0.3 
3  3  1  2 
3  2  1  2 
3  3  0  1 
2  2  0  2 
2.8 +  0.3  2.5 +  0.3  0.5 +  0.3  1.8 +  0.3 
Samples incubated with equal volumes of anti-serum or saline 1 h at 37°C; centrifuged at 15,000 rpm for 
30 min. Antisera absorbed previously with S. mutans or albumin-coated SRBC;  diluted  1:5 before use. 
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Fro.  8.  Proliferative response to OVA after adoptive transfer of cells from CBA/J mice given OVA 
or PBS IG. 40 ×  l0  p cells transferred to syngeneic mice from animals given PBS (open bar) or 20 mg 
OVA 2 d (hatched bar) or 4 d (stippled bar) previously. Mice were challenged with 100/.tg OVA in 
H37 Ra complete adjuvant subcutaneously 1 h after transfer of cells (IV). Mean :t: SE ofSI of LNC 
proliferative assay of four to five animals/group. Significant suppression (P <  0.05)  was noted on 
transfer of MLN cells from day-2 and -4 animals. Transfer of PP cells or spleen cells did not produce 
statistically significant suppression. S. J.  CHALLACOMBE  AND  T.  B.  TOMASI, Ja.  1467 
and S.  mutans was not  affected. Transfer of spleen cells led to less suppression than 
with MLN cells, and this was not statistically significant (P =  0.06 at 2 d). 
Transfer of cells  from mice given  10  ° S.  mutans  IG was performed at  1 and  3  d. 
Transfer of PP or spleen ceils did not lead to significant suppression. With MLN cells, 
suppression was found with cells taken at  3 d  (P <  0.02).  Feeding S.  rnutans did not 
alter the proliferative response to PPD or OVA. 
An attempt was also made to suppress the in vitro proliferative response of sensitized 
LNC. MLN cells were taken 4 d after IG immunization with OVA because cells taken 
at this time had been shown to transfer suppression to syngeneic recipients. Cells were 
incubated at various ratios (1:3, 1:1, and 3:1) with sensitized LNC taken from animals 
immunized 8 d  previously subcutaneously in the tail. No significant suppression was 
detected under these conditions. 
Sensitization  of PP by Antigen Given IG.  During experiments that showed the induc- 
tion of secretory antibodies after intragastric  immunization,  it was noted that  mice 
given OVA IG showed no proliferative response when  PP taken at  2 and 6  d  after 
intragastric administration were challenged in vitro with OVA (Table III). At  13 d 
after feeding, no proliferative response was found with 4 or 10 mg of OVA, whereas 
20 mg elicited a  slight but  questionably significant response (stimulation  index  [SI] 
=  2.2). In contrast, PP and MLN responded strongly to the intragastric immunization 
with S.  mutans at 6 and  13 d, and a slight response (SI =  2.5)  was noted in MLN at 2 
d  (Table  III). A  maximum response in  PP  (media:  3,826  ±  1,610  cpm;  cell  wall: 
59,941  ±  10,704 cpm; SI:  15.7) was obtained when 1.5 ×  109 organisms were given IG 
13 d  previously. However, significant stimulation was also obtained with concentra- 
tions as low as 3  ×  l0  s  (SI -- 9.9).  OVA and  S.  mutans are both excellent  antigens 
when administered subcutaneously, and in general induce approximately equivalent 
degrees of proliferation in regional LNC (as measured by counts per minute and SI). 
Thus, the differences noted here between these antigens on the proliferative response 
of PP after oral immunization stands in striking contrast  to their effect on regional 
lymph nodes when these same antigens are given subcutaneously with adjuvants. 
Discussion 
The phenomenon of systemic hyporesponsiveness after oral immunization appears 
to be well established and common to various species of experimental animals as well 
TABLE  III 
Proliferative Response after 1G Immunization with 0 VA and S. mutans 
SI* 
2d  6d  13d 
PP  MLN  Spl~n  PP  MLN  Spleen  PP 
OVA  1.0  1.0  1.1  1.0  1.0  1.1  2.2 
mutans  1.0  2.5  1.0  11.1  4.4  2.1  15.7 
In vitro proliferation response ofPP, MLN, and spleen at 2, 6, and 13 d after IG administration of 20 mg 
OVA and 1.5 ×  109 S. mutans.  In vitro concentration: OVA 500 #g/ml, S.  mutans cell wall 250/.tg/ml. 
* SI -- cpm in presence of antigen 
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as  man  (20,  21).  Oral  tolerance  has  been  described  to  T  dependent  and  not  T 
independent antigens, and only the T  cell appears to be tolerized (4). Oral immuni- 
zation with OVA has been reported to suppress various systemic reactions including 
passive cutaneous anaphylaxis (3), T  cell proliferation (9), and plaque-forming cells 
(9). A  recent editorial (22)  reviews the phenomenon of oral tolerance and its impli- 
cations. Recently, Swarbrick et al. (23) showed that prior feeding of antigen may lead 
not only to suppression of the induction of serum antibodies, but also to a reduction 
in the subsequent absorption of antigen, presumably a function of local immunity as 
previously suggested by Walker et al.  (24).  The current findings extend this concept 
and suggest that the secretory system can be stimulated at the same time that systemic 
tolerance and suppressor cells are induced. 
There is an apparent  paradox in that  PP have been postulated to play a  central 
role both  in  the  induction  of suppressor  cells,  and  in  the  production  of antigen- 
sensitive cells. Thus, in other studies, suppression after intragastric immunization has 
been transferred by PP cells (7, 8,  10), and yet PP are also believed to be the source 
of the  antigen-sensitive  cells  found  in  the  secretory system  (11,  12).  The  relative 
deficiency of antigen-presenting cells in PP (25), at least for certain antigens, could 
theoretically contribute to the ease with which suppression can be induced by this 
route because the absence of macrophages appears to favor the induction of suppressor 
cells (26-28), and responses to both OVA  (18)  and S.  mutans (Table I) appear to be 
macrophage-dependent. Recently, IgA-specific helper T  cells have been identified in 
PP (29) and, therefore, it appears that the PP can be a source of both suppressor and 
helper cells. It is possible that there is a  relative predominance of T  suppressors for 
IgG and IgM (as well as for delayed reactions) in PP, whereas suppressor cells specific 
for IgA are deficient compared with IgA helper cells.  In our studies, suppression was 
not adoptively transferred with PP cells, but was transferred with MLN cells.  This 
may  indicate  that  in  the  system  used,  cells  from  the  patches  require  a  period  of 
maturation in  the mesenteric nodes to become fully effective in suppression.  Alter- 
natively, and  perhaps  more  likely,  if suppression  is  mediated  by T  cells,  as  other 
reports suggest,  then  the relative proportions of T  cells in  PP  (37%)  to mesenteric 
nodes (80%) (17) could explain the ease of transfer of suppression by mesenteric nodes 
in comparison with PP. Further studies are now in progress that attempt to define the 
sequence of appearance of suppressor cells of various isotypes in different tissues, the 
cell type(s) involved, and whether suppressor cells and soluble factors are responsible 
for the initiation and/or maintenance of oral tolerance. 
Whereas both particulate and soluble antigens were shown to induce salivary IgA 
antibodies, the profound suppression achieved with OVA was in contrast to the weak 
suppression  found  with  S.  mutans.  There  are  several  possible  explanations.  The 
proliferative response to OVA is entirely a T  cell response, whereas the response to S. 
mutans,  although predominantly a  T  cell response  (Table I), could contain a  B cell 
component. It has been suggested that the response to T  independent antigens is not 
suppressed  after oral immunization,  in contrast  to T  dependent antigens  (4).  The 
observation that intragastric immunization with S. mutans, but not with OVA, induced 
a  proliferative response in  PP  (Table III)  further suggests  that  the  immunological 
response to certain antigens, perhaps more particulate and complex antigens, may be 
different  from  that  induced  by others  such  as  soluble  readily  degradable  protein 
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overlying the patch (30). Although it is unclear how long soluble antigens may remain 
in the patch, particulate antigens may possibly persist for a considerable time because 
carbon particles have been found in subepithelial macrophages for as long as 2 mo 
after ingestion (3 I). Thus, differences in the distribution and macrophage uptake or 
presentation between particulate and soluble antigens in the patch may account for 
differences in immunological responses. 
In this investigation, adoptive transfer experiments indicated that  suppression of 
the  proliferative  response  could  be  mediated  by  suppressor  cells  before  in  vivo 
sensitization, but,  in common with other studies,  (9)  in  vitro proliferation was  not 
suppressed. This suggests that suppression may occur in the induction phase of the 
immune response, perhaps via an effect on the T  helper cells (4, 32). The suppressor 
cells induced after intragastric immunization with either OVA or S.  mutans appeared 
to  be  antigen-specific in  that  systemic challenge  with  the  homologous and  not  a 
heterologous antigen  was  suppressed.  Interestingly,  the  response  to  PPD  was  also 
suppressed,  but  only in  those animals  challenged with  the same  antigen  that  had 
been given IG. It seems likely, therefore, that after specific induction, the proliferation 
of suppressor cells may include some nonspecific suppressor cells (33)  or factors (34, 
35) that will suppress the response to a second antigen given concurrently. Although 
suppressor T  cells (4, 9,  10) and suppressor B cells (8) have been demonstrated after 
oral feeding, serum factors may also play a role (5, 6). Serum suppressive factors were 
not examined in this study, and it remains possible that suppressor cells and serum 
factors could be produced simultaneously. It should also be stressed that the presence 
of suppressor ceils was examined in this study only early in the response (2-4 d), and 
further studies are required to determine if the long-lasting (>60 d)  tolerance after 
intragastric immunization results from active suppression or some alternative mech- 
anism. There is evidence that in certain circumstances the presence of suppressor cells 
and  tolerance may not  be related as cause and effect. In  tolerance induced by the 
systemic injection of human  gammaglobulin,  tolerance may occur in  the apparent 
absence of suppressor cells; even when suppressor cells are present, they may not be 
entirely responsible for the maintenance of tolerance (36). 
Although systemic suppression has been demonstrated after feeding or intragastric 
administration of a variety of soluble antigens, and in this study with whole bacterial 
cells,  it  is  not  necessarily a  general  phenomenon,  and  some  antigens  given  orally 
induce  a  systemic immune  response.  Whether  tolerance or  immunity  follows oral 
administration of an antigen depends not only on its chemical nature and dose but on 
whether the animal has had prior contact with the antigen (4, 37). S.  mutans is not a 
normal component of the murine flora; bacteria, which are part of the intestinal flora, 
may induce different responses. 
The  demonstration  that  intragastric  immunization  may  lead  to  simultaneous 
induction of secretory antibodies and systemic suppression raises intriguing specula- 
tion as to the relationship between the two systems and the biological relevance of 
these  observations.  The occurrence of a  secretory immune  response  after mucosal 
contact  with  antigen would appear to be a  useful  mechanism  for the exclusion of 
potentially harmful substances from the body (20), whereas the induction of systemic 
tolerance could act as a secondary defense to ensure that immunologically damaging 
reactions to antigens that escape exclusion mechanisms do not occur. This may be a 1470  SECRETORY  ANTIBODIES AND SYSTEMIC TOLERANCE 
particularly  appropriate  response  to  various  allergens  (3,  10)  and  to  antigens  that 
cross-react with self and, therefore, might induce autoimmunity. 
Summary 
Diminished systemic immune reaction after ingestion of antigen has been reported 
in several animal models. Conversely, it has been reported recently that oral immu- 
nization  may lead to the production of secretory antibodies. To determine whether 
these events could occur concurrently, CBA/J mice were immunized intragastrically 
with varying doses ofovalbumin (OVA) and Streptococcus  mutans. After 7 d, the animals 
were challenged systemically with antigen in complete adjuvant, and 8 d later serum 
and saliva taken, and the draining lymph nodes assayed for a  proliferative response. 
Intragastric doses of 1 mg OVA or  10  9 S.  mutans led to significant suppression of the 
proliferative response, and intragastric doses of 10 mg OVA or 2.5 X  109 S. mutans led 
to the production  of detectable salivary antibodies  using hemagglutination.  Serum 
antibodies were not  detected after intragastric administration  of OVA or S.  mutans. 
Suppression of the proliferative response could be detected  from 2-60 d  after intra- 
gastric administration of OVA, and 2-21  d  after S.  mutans.  Prior intragastric immu- 
nization with heterologous antigens did not suppress the response to OVA or S. mutans. 
Transfer of 40 ×  106 mesenteric lymph node cells from mice given 20 mg OVA or 10  a 
S.  mutans  led  to  suppression  of the  proliferative response  in  syngeneic  recipients. 
Salivary antibodies were removed by absorption with anti-IgA, but not anti-IgG or 
IgM, indicating that they were of the IgA class. It appears that intragastric adminis- 
tration of soluble or particulate antigens in mice may lead to the concurrent induction 
of salivary antibodies and systemic suppression. 
Received  for publication 7July  1980. 
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